Infectious Diseases News and Research

RSS

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States.

31 Mar 2022

Study estimates the comparative abundance of SARS-CoV-2 variants via wastewater monitoring

A recent study estimated the comparative abundance of SARS-CoV-2 variants via wastewater monitoring.

31 Mar 2022

Despite doctors’ concerns, pharmacists get more leeway to offer treatment with testing

When Reyna or Justin Ansley or one of their three kids feels sick and needs to be tested for strep throat or flu, there's a good chance they'll head to their local pharmacy in Hemingford or Alliance, Nebraska. Dave Randolph, the proprietor of both locations of Dave's Pharmacy, can do a rapid test, give them medicine if they need it, and send them on their way.

31 Mar 2022

Common coronavirus infections don't generate antibodies that effectively cross-react with SARS-CoV-2

Although SARS-CoV-2 has taken the world by storm, it's not the only coronavirus that can infect humans.

30 Mar 2022

Clinical trials for experimental HIV vaccines based on mRNA technology begin in United States

Scientists urge African leaders to demand fair licensing following clinical trials of an HIV vaccine candidate.

30 Mar 2022

Virtual reality helps reduce COVID-19 vaccine hesitancy

A new study investigates whether intention for vaccination is increased by a gamified immersive VR experience that shows how community immunity works.

28 Mar 2022

Northwestern scientists continue to advance the understanding of COVID-19

As the COVID-19 pandemic enters its third year, Northwestern Medicine scientists continue to help advance the understanding of the disease and its impact, from investigating antibody protection against COVID-19 reinfection to elevating women in academic research and highlighting racial and ethnic disparities in COVID-19 hospital mortality in Illinois.

28 Mar 2022

Black patients with cancer experience worse outcomes after COVID-19 diagnosis

Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open.

28 Mar 2022

Climate change may push the US toward the ‘goldilocks zone’ for West Nile virus

Michael Keasling of Lakewood, Colorado, was an electrician who loved big trucks, fast cars, and Harley-Davidsons. He'd struggled with diabetes since he was a teenager, needing a kidney transplant from his sister to stay alive.

28 Mar 2022

Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

Researchers discuss the results of a clinical trial to assess the efficacy and safety of IV sarilumab for the treatment of hospitalized COVID-19 patients.

27 Mar 2022

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

A preliminary study to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal (23-26 April), suggests that people living with HIV who are on antiretroviral treatment (ART) with protease inhibitors (PI), may have a lower risk of COVID-19 infection.

27 Mar 2022

Combination of Covid-19 and flu linked to greater risk of severe disease, death

Adults in hospital who have Covid-19 and the flu at the same time are at much greater risk of severe disease and death compared with patients who have Covid-19 alone or with other viruses, research shows.

27 Mar 2022

The intercontinental spread of high-pathogenic avian influenza A (H5N1) virus

Researchers aim to better understand the landscape movement of the avian influenza virus.

24 Mar 2022

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Antibiotic resistance is a growing problem worldwide that threatens the efficacy of available treatments and can lead to extended hospital stays and increased mortality.

24 Mar 2022

Tuberculosis perturbs epigenetic processes to promote premature cellular aging

Tuberculosis (TB) is a potentially serious infectious disease caused by a type of bacterium called Mycobacterium tuberculosis.

24 Mar 2022

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

Researchers assessed the prevalence of antibodies that neutralize the type I interferon antiviral activity and reactivate herpesviruses such as herpes simplex virus types 1 and 2 and/or cytomegalovirus infections in patients with critical COVID-19.

24 Mar 2022

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

For World Tuberculosis Day 2022, News Medical spoke to Dr. Maxine Caws to raise awareness of this infectious disease.

24 Mar 2022

World Tuberculosis Day 2022: an interview with Dr. Michael Lauzardo

For World Tuberculosis Day 2022, News Medical spoke to Dr. Michael Lauzardo, director of the Southeastern National TB Center, to raise awareness of this infectious disease.

24 Mar 2022

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use.

23 Mar 2022

Novel non-extensive statistical model to study COVID-19 epidemic distribution

Researchers modified and developed a SIR model within the framework of non-extensive statistics to show the complexity of the global COVID-19 epidemic distribution.

23 Mar 2022

Infectious Diseases News and Research

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

Study estimates the comparative abundance of SARS-CoV-2 variants via wastewater monitoring

Despite doctors’ concerns, pharmacists get more leeway to offer treatment with testing

Common coronavirus infections don't generate antibodies that effectively cross-react with SARS-CoV-2

Clinical trials for experimental HIV vaccines based on mRNA technology begin in United States

Virtual reality helps reduce COVID-19 vaccine hesitancy

Northwestern scientists continue to advance the understanding of COVID-19

Black patients with cancer experience worse outcomes after COVID-19 diagnosis

Climate change may push the US toward the ‘goldilocks zone’ for West Nile virus

Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

Combination of Covid-19 and flu linked to greater risk of severe disease, death

The intercontinental spread of high-pathogenic avian influenza A (H5N1) virus

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Tuberculosis perturbs epigenetic processes to promote premature cellular aging

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

World Tuberculosis Day 2022: an interview with Dr. Michael Lauzardo

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Novel non-extensive statistical model to study COVID-19 epidemic distribution

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News